“Wound gel growth tracks chronic wound prevalence, not innovation cycles”

"Wound gel growth tracks chronic wound prevalence, not innovation cycles."

This is one of the steadier, lower-growth categories in this batch, tied closely to diabetes and pressure ulcer incidence rather than to any pending technology shift.